We are live on ! Find out more
AEMD icon

Aethlon Medical

9 hedge funds and large institutions have $61K invested in Aethlon Medical in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0%0% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

31% less funds holding

Funds holding: 139 (-4)

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

67% less capital invested

Capital invested by funds: $185K → $61K (-$124K)

Holders
9
Holders Change
-4
Holders Change %
-30.77%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
1
Closed
7
Calls
Puts
Net Calls
Net Calls Change

AEMD Hedge Fund Activity: Q4 2019 in Review

9 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q4 2019, worth a combined $61K — down 67% from $185K a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of AEMD and 3 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $71.7K. The largest seller was Geode Capital Management, exiting entirely with an estimated $29K sold.

  • 9 institutional investors held Aethlon Medical (AEMD) as of Q4 2019, down from 13 in Q3 2019.
  • Funds reported $61K of Aethlon Medical stock for Q4 2019, down 67% quarter-over-quarter.
  • 3 funds opened new Aethlon Medical positions in Q4 2019 and 7 closed out, a net change of -4 holders.
  • The largest Aethlon Medical buyer in Q4 2019 was Renaissance Technologies, an estimated $71.7K added.
  • The largest Aethlon Medical seller in Q4 2019 was Geode Capital Management, an estimated $29K sold.

Based on aggregated 13F filings for Q4 2019.